Published in J Clin Pathol on September 24, 2007
Serum markers of hepatocellular carcinoma. Dig Dis Sci (2010) 1.76
Diagnosis of hepatocellular carcinoma. World J Gastroenterol (2009) 1.39
Tumor markers for hepatocellular carcinoma. Mol Clin Oncol (2013) 1.35
Elevated expression of squamous cell carcinoma antigen (SCCA) is associated with human breast carcinoma. PLoS One (2011) 1.13
Tissue expression of squamous cellular carcinoma antigen and Ki67 in hepatocellular carcinoma-correlation with prognosis: a historical prospective study. Diagn Pathol (2011) 1.07
SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis. Br J Cancer (2014) 1.03
Oncogenic Ras induces inflammatory cytokine production by upregulating the squamous cell carcinoma antigens SerpinB3/B4. Nat Commun (2014) 1.01
Hepatic progenitor cells express SerpinB3. BMC Cell Biol (2014) 0.89
Tissue expression of Squamous Cellular Carcinoma Antigen (SCCA) is inversely correlated to tumor size in HCC. Mol Cancer (2009) 0.88
SERPINB3 protects from oxidative damage by chemotherapeutics through inhibition of mitochondrial respiratory complex I. Oncotarget (2014) 0.88
Biomarkers for the early diagnosis of hepatocellular carcinoma. World J Gastroenterol (2015) 0.85
Tissue- and Serum-Associated Biomarkers of Hepatocellular Carcinoma. Biomark Cancer (2016) 0.85
Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells. Oncotarget (2015) 0.83
IgM-linked SerpinB3 and SerpinB4 in sera of patients with chronic liver disease. PLoS One (2012) 0.79
An update of biochemical markers of hepatocellular carcinoma. Int J Health Sci (Qassim) (2016) 0.79
An Overview of Biomarkers and Molecular Signatures in HCC. Cancers (Basel) (2010) 0.77
SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity. Sci Rep (2015) 0.76
SERPINB3 is associated with longer survival in transgenic mice. Sci Rep (2013) 0.76
Clinical applications of squamous cell carcinoma antigen-immunoglobulins M to monitor chronic hepatitis C. World J Hepatol (2015) 0.75
Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold Nanoparticles. Bioconjug Chem (2016) 0.75
SERPINB3 (serpin peptidase inhibitor, clade B (ovalbumin), member 3). Atlas Genet Cytogenet Oncol Haematol (2015) 0.75
Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med (1991) 4.68
Malignant angiomyolipoma of the liver: a hitherto unreported variant. Histopathology (2000) 3.24
HCV-associated liver cancer without cirrhosis. Lancet (1995) 3.23
Gastric epithelial dysplasia in the natural history of gastric cancer: a multicenter prospective follow-up study. Interdisciplinary Group on Gastric Epithelial Dysplasia. Gastroenterology (1994) 3.15
Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab (1999) 3.00
The canals of Hering and hepatic stem cells in humans. Hepatology (1999) 2.93
Hepatic angiomyolipoma: a clinicopathologic study of 30 cases and delineation of unusual morphologic variants. Am J Surg Pathol (1999) 2.53
Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV. Lancet (1992) 2.44
The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin. Histopathology (2006) 2.18
Comfrey herb tea-induced hepatic veno-occlusive disease. Am J Med (1989) 2.09
Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. Gastroenterology (1980) 2.04
HMB-45 reactivity in adrenal pheochromocytomas. Arch Pathol Lab Med (1992) 2.03
Clinical evaluation of safety and efficacy of Boswellia-based cream for prevention of adjuvant radiotherapy skin damage in mammary carcinoma: a randomized placebo controlled trial. Eur Rev Med Pharmacol Sci (2015) 2.02
Synthesis in animal cells of hepatitis B surface antigen particles carrying a receptor for polymerized human serum albumin. Proc Natl Acad Sci U S A (1984) 2.00
The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology (1992) 1.85
Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial. Hepatology (1997) 1.77
Natural history and prognostic factors for chronic hepatitis type B. Gut (1991) 1.75
Hepatic 'stem cell' malignancies in adults: four cases. Histopathology (2003) 1.73
Gastroenterological oncology: a top priority. Dig Liver Dis (2000) 1.70
Hepatitis C virus infection in chronic hepatitis B virus carriers. J Infect Dis (1991) 1.69
Histological features after liver transplantation in alcoholic cirrhotics. J Hepatol (2001) 1.69
Primary liver tumour of intermediate (hepatocyte-bile duct cell) phenotype: a progenitor cell tumour? Liver (1998) 1.67
Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis. Gut (2008) 1.65
Chronic atrophic gastritis and Helicobacter pylori infection in primary biliary cirrhosis: a cross-sectional study with matching. Ital J Gastroenterol Hepatol (1997) 1.63
Long-term follow-up of acute and chronic non-A, non-B post-transfusion hepatitis: evidence of progression to liver cirrhosis. Gut (1982) 1.60
Telomerase activity in precancerous hepatic nodules. Cancer (1998) 1.59
Early and advanced gastric cancer in the follow-up of moderate and severe gastric dysplasia patients. A prospective study. I.G.G.E.D.--Interdisciplinary Group on Gastric Epithelial Dysplasia. Endoscopy (1993) 1.58
Oxidative DNA damage accumulation in gastric carcinogenesis. Gut (1998) 1.57
Nimesulide-induced acute hepatitis: evidence from six cases. J Hepatol (1998) 1.55
A randomized controlled trial of lymphoblastoid interferon-alpha in patients with chronic hepatitis B lacking HBeAg. Hepatology (1992) 1.52
Fine needle aspiration of non-small cell lung cancer: current state and future perspective. Cytopathology (2012) 1.52
Spontaneous regression of hepatitis B virus-associated cirrhosis developed in childhood. Dig Liver Dis (2005) 1.51
Digestive neuroendocrine tumours: diagnosis and treatment in Italy. A survey by the Oncology Study Section of the Italian Society of Gastroenterology (SIGE). Dig Liver Dis (2001) 1.50
Histiocytes in Sweet's syndrome. Br J Dermatol (1991) 1.49
Idiopathic noncirrhotic portal hypertension is associated with poor survival: results of a long-term cohort study. Aliment Pharmacol Ther (2012) 1.49
Oestrogen receptor B-region polymorphism and spontaneous abortion in women with breast cancer. Lancet (1990) 1.49
Detection of hepatitis B virus DNA in mononuclear blood cells. Br Med J (Clin Res Ed) (1984) 1.49
Bovine lactoferrin for Helicobacter pylori eradication: an open, randomized, multicentre study. Aliment Pharmacol Ther (2006) 1.48
Autoimmune gastritis: histology phenotype and OLGA staging. Aliment Pharmacol Ther (2012) 1.48
Serum levels of soluble interleukin-2 receptors in acute and chronic viral hepatitis. Dig Dis Sci (1989) 1.47
Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors. Hepatology (2001) 1.46
p53 alteration in gastric precancerous lesions. Am J Pathol (1994) 1.45
The prevalence of oesophageal eosinophilia and eosinophilic oesophagitis: a prospective study in unselected patients presenting to endoscopy. Aliment Pharmacol Ther (2013) 1.45
bcl-2 and p53 immunophenotypes in pre-invasive, early and advanced oesophageal squamous cancer. Histopathology (1997) 1.43
Molecular and cellular pathology of hepatitis B. Lab Invest (1985) 1.43
Detection of hepatitis B and hepatitis C viral sequences in fulminant hepatic failure of unknown etiology. Am J Clin Pathol (1995) 1.43
Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer (1999) 1.43
Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology (1996) 1.42
HLA-DR expression in bile duct damage in hepatitis C. Mod Pathol (1993) 1.42
The histologic effects of low-dose methotrexate therapy for primary biliary cirrhosis. Arch Pathol Lab Med (1998) 1.42
Hepatic fibrogenesis requires sympathetic neurotransmitters. Gut (2004) 1.42
Microbiologic contamination of intraoperative blood salvaged during liver transplantation. Transplant Proc (2007) 1.41
Upper gastrointestinal injury caused by diquat. Gastrointest Endosc (1992) 1.41
Ductular reaction in the liver. Pathol Res Pract (1995) 1.39
The micronucleus assay in exfoliated cells of the human buccal mucosa. Mutagenesis (1987) 1.38
Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B. Hepatology (1986) 1.38
Hormonal treatment of hepatocellular carcinoma. J Hepatol (1991) 1.38
The long term outcome of gastric non-invasive neoplasia. Gut (2003) 1.37
Distribution of five antigens in hepatocellular carcinoma. Lab Invest (1979) 1.35
Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update. J Hepatol (2007) 1.33
Deep intralobular extension of human hepatic 'progenitor cells' correlates with parenchymal inflammation in chronic viral hepatitis: can 'progenitor cells' migrate? J Pathol (2000) 1.32
Hepatic epithelioid hemangioendothelioma: resection or transplantation, which and when? Liver Transpl Surg (1999) 1.32
Neoangiogenesis and sinusoidal "capillarization" in dysplastic nodules of the liver. Am J Surg Pathol (1998) 1.30
Hepatic progenitor cells in hepatocellular adenomas. Am J Surg Pathol (2001) 1.29
The immunohistochemical phenotype of dysplastic foci in human liver: correlation with putative progenitor cells. J Hepatol (2000) 1.28
Helicobacter pylori infection enhances mucosal interleukin-1 beta, interleukin-6, and the soluble receptor of interleukin-2. Int J Clin Lab Res (1996) 1.28
Differential distribution of hepatitis B core and E antigens in hepatocytes: analysis by monoclonal antibodies. Hepatology (1986) 1.26
Identification of bipotential progenitor cells in human liver regeneration. Lab Invest (1996) 1.26
Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis. Hepatology (1997) 1.24
Association between reactive oxygen species and disease activity in chronic hepatitis C. Free Radic Biol Med (1996) 1.24
Topographic patterns of intestinal metaplasia and gastric cancer. Am J Gastroenterol (2000) 1.24
Loss of FHIT expression in gastric carcinoma. Cancer Res (1998) 1.23
Helicobacter pylori babA2, cagA, and s1 vacA genes work synergistically in causing intestinal metaplasia. J Clin Pathol (2003) 1.23
Long-term follow-up of anti-HBe-positive chronic active hepatitis B. Hepatology (1988) 1.23
Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood. Gastroenterology (1990) 1.23
Liver cell apoptosis in chronic hepatitis C correlates with histological but not biochemical activity or serum HCV-RNA levels. Hepatology (2000) 1.21
Helicobacter pylori virulence genes and host IL-1RN and IL-1beta genes interplay in favouring the development of peptic ulcer and intestinal metaplasia. Cytokine (2002) 1.20
Serum and liver HCV RNA levels in patients with chronic hepatitis C: correlation with clinical and histological features. Gut (1998) 1.20
Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non-cirrhotic and cirrhotic chronic viral hepatitis. Histopathology (2001) 1.20
Potential gastrointestinal tumor suppressor locus at the 3p14.2 FRA3B site identified by homozygous deletions in tumor cell lines. Cancer Res (1996) 1.19
The effect of interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C. J Hepatol (1995) 1.19
In situ detection of hepatitis B, C, and G virus nucleic acids in human hepatocellular carcinoma tissues from different geographic regions. Hepatology (1998) 1.19
Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma. Am J Transplant (2010) 1.18
Adverse effects of FK 506 overdosage after liver transplantation. Transplant Proc (1993) 1.18
Origin of spurious multiple bands in the amplification of microsatellite sequences. Mol Pathol (1999) 1.18
Chronic hepatitis C in children: the pathological and clinical spectrum. Gastroenterology (1998) 1.17
Cloning and expression of a novel hepatitis B virus-binding protein from HepG2 cells. J Biol Chem (2001) 1.17
Fez1/lzts1 alterations in gastric carcinoma. Clin Cancer Res (2001) 1.17
Definition of hepatitis B virus (HBV)-specific target antigens recognized by cytotoxic T cells in acute HBV infection. Clin Exp Immunol (1987) 1.16
Morphologic, immunohistochemical, and ultrastructural studies of the production of hepatitis B virus in vitro. Lab Invest (1988) 1.15
Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study. Aliment Pharmacol Ther (2010) 1.15
The interaction between hepatitis B virus and hepatitis C virus in acute and chronic liver disease. J Hepatol (1995) 1.14
Gastric epithelial dysplasia. How clinicopathologic background relates to management. Cancer (1995) 1.13
Patterns of antibodies to hepatitis C virus in patients with chronic non-A, non-B hepatitis and their relationship to viral replication and liver disease. Hepatology (1993) 1.13